Topic - Sprout Pharmaceuticals

Related Stories

In this June 22, 2015, photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. The Food and Drug Administration on Tuesday, Aug. 18, 2015, approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to replicate the blockbuster success of impotence drugs for men. (AP Photo/Allen G. Breed/File)

Q&A: What you need to know about new female libido pill

By Matthew Perrone - Associated Press

The panel of Food and Drug Administration advisers voted 18-6 in favor of Sprout Pharmaceutical's daily pill, flibanserin, on the condition that the company develops a plan to manage its risks. (Associated Press)

‘Female Viagra’ equivalent wins FDA panel’s approval, under safety conditions

By Matthew Perrone - Associated Press

FILE - In this Friday, Sept. 27, 2013, file photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. Sprout Pharmaceuticals said Tuesday, Feb. 11, 2014, that the Food and Drug Administration wants to see more data on how the company's drug, flibanserin, interacts with other medications and how it affects driving ability. Nearly 10 percent of women studied in company trials reported sleepiness while taking the daily pill. (AP Photo/Allen G. Breed)

FDA wants more info on female libido pill

By MATTHEW PERRONE - Associated Press